• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征对日本特定健康检查和指导计划参与者死亡率的影响。

Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan.

机构信息

Clinical Research Support Center, Nakamura Clinic, Japan.

Department of Public Health and Hygiene, Yamagata University School of Medicine, Japan.

出版信息

Intern Med. 2020 Nov 1;59(21):2671-2678. doi: 10.2169/internalmedicine.4975-20. Epub 2020 Jul 14.

DOI:10.2169/internalmedicine.4975-20
PMID:32669499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7691040/
Abstract

Objective In Japan, the Specific Health Check and Guidance (Tokutei-Kenshin) program was started in 2008 to decrease the social burden related to metabolic syndrome (MetS). However, so far this program has not been found to have any impact on the mortality rate. Methods The subjects consisted of individuals who participated in the Tokutei-Kenshin in seven districts between 2008 and 2015. Using a National database of death certificates, we identified those who might have died and then further confirmed such deaths with the collaboration of the regional National Health Insurance agency and public health nurses. The diagnosis of MetS was made according to the Japanese criteria. The causes of death were classified by ICD-10. Mortality risk was evaluated after adjusting for age, sex, smoking, alcohol intake and past medical history such as stroke, heart disease and kidney disease. Results Among the total of 664,926 subjects, we identified 8,051 fatal cases by the end of 2015. The crude death rate was 1.6% for those with MetS, 1.3% for those with preliminary metabolic syndrome, and 1.1% those without MetS. In MetS, the adjusted hazard ratio (95% confidence interval) was 1.08 (1.02-1.15) for all-cause and 1.39 (1.22-1.58) for cardiovascular disease mortality when the reference was for those without MetS. Conclusion The death rate was found to be significantly higher among the participants with MetS.

摘要

目的

2008 年,日本启动了特定健康检查和指导(Tokutei-Kenshin)计划,以降低与代谢综合征(MetS)相关的社会负担。然而,到目前为止,该计划尚未发现对死亡率有任何影响。

方法

研究对象为 2008 年至 2015 年间参加特定健康检查和指导的七个地区的个体。我们利用国家死亡证明数据库,确定可能已经死亡的人,并与地区国家健康保险机构和公共卫生护士合作进一步确认这些死亡。代谢综合征的诊断符合日本标准。死因按 ICD-10 分类。死亡率风险在调整年龄、性别、吸烟、饮酒以及中风、心脏病和肾病等既往病史后进行评估。

结果

在总计 664926 名受试者中,我们在 2015 年底确定了 8051 例死亡病例。代谢综合征患者的粗死亡率为 1.6%,初步代谢综合征患者为 1.3%,无代谢综合征患者为 1.1%。在代谢综合征中,全因死亡的调整后危险比(95%置信区间)为 1.08(1.02-1.15),心血管疾病死亡的调整后危险比为 1.39(1.22-1.58),以无代谢综合征为参照。

结论

代谢综合征患者的死亡率明显更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/a2761f247e18/1349-7235-59-2671-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/fafbe2c26815/1349-7235-59-2671-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/0134096bf750/1349-7235-59-2671-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/a2761f247e18/1349-7235-59-2671-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/fafbe2c26815/1349-7235-59-2671-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/0134096bf750/1349-7235-59-2671-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3d/7691040/a2761f247e18/1349-7235-59-2671-g003.jpg

相似文献

1
Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan.代谢综合征对日本特定健康检查和指导计划参与者死亡率的影响。
Intern Med. 2020 Nov 1;59(21):2671-2678. doi: 10.2169/internalmedicine.4975-20. Epub 2020 Jul 14.
2
Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.2008 - 2012年日本特定健康检查与指导项目筛查对象的死亡风险
Clin Exp Nephrol. 2017 Dec;21(6):978-985. doi: 10.1007/s10157-017-1392-y. Epub 2017 Mar 3.
3
Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.代谢综合征与全因死亡率及心血管疾病死亡率:基于日本公共卫生中心的前瞻性研究(JPHC研究)
Circ J. 2009 May;73(5):878-84. doi: 10.1253/circj.cj-08-1025. Epub 2009 Mar 12.
4
Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in Japan.尿沉渣血尿与普通人群全因死亡率的相关性:来自日本专项健康检查与指导项目的结果。
Nephrol Dial Transplant. 2018 May 1;33(5):825-832. doi: 10.1093/ndt/gfx213.
5
Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.代谢综合征及其组分与心血管疾病风险:RIVANA 队列的 13 年前瞻性研究。
Cardiovasc Diabetol. 2020 Nov 22;19(1):195. doi: 10.1186/s12933-020-01166-6.
6
Dipstick proteinuria and all-cause mortality among the general population.普通人群中的试纸法蛋白尿与全因死亡率
Clin Exp Nephrol. 2018 Dec;22(6):1331-1340. doi: 10.1007/s10157-018-1587-x. Epub 2018 Jun 5.
7
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.基于人群的前瞻性队列研究:代谢综合征状态变化与全因和心血管疾病相关死亡率风险的改变。
Diabetes Metab. 2023 May;49(3):101415. doi: 10.1016/j.diabet.2022.101415. Epub 2022 Dec 20.
8
Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study.日本普通人群中代谢综合征与心血管疾病死亡率的关联:超重和非超重个体的研究结果。茨城县健康研究。
Circ J. 2009 Sep;73(9):1635-42. doi: 10.1253/circj.cj-08-0442. Epub 2009 Jul 9.
9
The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly.代谢综合征增加台湾老年人的心血管疾病死亡率。
Eur J Clin Invest. 2008 Jul;38(7):469-75. doi: 10.1111/j.1365-2362.2008.01965.x. Epub 2008 May 23.
10
Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.代谢综合征与马来西亚成年人心血管疾病死亡率和全因死亡率风险的关联:一项回顾性队列研究。
BMJ Open. 2021 Aug 18;11(8):e047849. doi: 10.1136/bmjopen-2020-047849.

引用本文的文献

1
Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) and mortality among survivors of liver cirrhosis: a prospective cohort study.可发酵的低聚糖、双糖、单糖和多元醇(FODMAPs)与肝硬化幸存者的死亡率:一项前瞻性队列研究。
Nutr J. 2025 Jan 25;24(1):15. doi: 10.1186/s12937-025-01086-9.
2
Impact of Serotonin Transporter Absence on Brain Insulin Receptor Expression, Plasma Metabolome Changes, and ADHD-like Behavior in Mice fed a Western Diet.缺乏血清素转运体对西方饮食喂养的小鼠大脑胰岛素受体表达、血浆代谢组变化和 ADHD 样行为的影响。
Biomolecules. 2024 Jul 23;14(8):884. doi: 10.3390/biom14080884.
3

本文引用的文献

1
Metabolic syndrome is a risk factor for cancer mortality in the general Japanese population: the Jichi Medical School Cohort Study.代谢综合征是日本普通人群癌症死亡的一个风险因素:秩父 Memorial 医院队列研究。
Diabetol Metab Syndr. 2019 Jan 9;11:3. doi: 10.1186/s13098-018-0398-2. eCollection 2019.
2
Dipstick proteinuria and all-cause mortality among the general population.普通人群中的试纸法蛋白尿与全因死亡率
Clin Exp Nephrol. 2018 Dec;22(6):1331-1340. doi: 10.1007/s10157-018-1587-x. Epub 2018 Jun 5.
3
Glucosuria and all-cause mortality among general screening participants.
The Association between Uric Acid and Metabolic Syndrome in a Middle-Aged and Elderly Taiwanese Population: A Community-Based Cross-Sectional Study.
台湾中老年人群中尿酸与代谢综合征的关联:一项基于社区的横断面研究。
Healthcare (Basel). 2024 Jan 3;12(1):113. doi: 10.3390/healthcare12010113.
4
Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.日本用于优化心血管疾病预测的代谢综合征新标准的实用性。
J Atheroscler Thromb. 2024 Apr 1;31(4):382-395. doi: 10.5551/jat.64380. Epub 2023 Nov 17.
5
The Effect of a mHealth App (KENPO-app) for Specific Health Guidance on Weight Changes in Adults With Obesity and Hypertension: Pilot Randomized Controlled Trial.KENPO 应用程序(mHealth 应用程序)对特定健康指导在肥胖和高血压成年人体重变化中的影响:试点随机对照试验。
JMIR Mhealth Uhealth. 2023 Apr 12;11:e43236. doi: 10.2196/43236.
6
Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) study.代谢综合征和代谢不健康肥胖与癌症死亡率的关联:日本多机构合作队列研究(J-MICC 研究)。
PLoS One. 2022 Jul 8;17(7):e0269550. doi: 10.1371/journal.pone.0269550. eCollection 2022.
7
Association of metabolic syndrome traits with urinary biomarkers in Japanese adults.日本成年人代谢综合征特征与尿液生物标志物的关联
Diabetol Metab Syndr. 2022 Jan 15;14(1):9. doi: 10.1186/s13098-021-00779-5.
8
The Effect of CKD on Associations between Lifestyle Factors and All-cause, Cancer, and Cardiovascular Mortality: A Population-based Cohort Study.慢性肾脏病对生活方式因素与全因、癌症和心血管死亡率之间关联的影响:基于人群的队列研究。
Intern Med. 2021 Jul 15;60(14):2189-2200. doi: 10.2169/internalmedicine.6531-20. Epub 2021 Feb 15.
普通筛查参与者中的糖尿与全因死亡率
Clin Exp Nephrol. 2018 Aug;22(4):850-859. doi: 10.1007/s10157-017-1528-0. Epub 2018 Jan 12.
4
Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in Japan.尿沉渣血尿与普通人群全因死亡率的相关性:来自日本专项健康检查与指导项目的结果。
Nephrol Dial Transplant. 2018 May 1;33(5):825-832. doi: 10.1093/ndt/gfx213.
5
Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.贫血作为全因死亡率的危险因素:慢性肾脏病的隐匿协同效应
Clin Exp Nephrol. 2018 Apr;22(2):388-394. doi: 10.1007/s10157-017-1468-8. Epub 2017 Aug 16.
6
Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.社区老年人群中肾功能与心血管疾病及全因死亡率的关联:来自日本特定健康检查与指导项目的结果
Clin Exp Nephrol. 2018 Apr;22(2):346-352. doi: 10.1007/s10157-017-1455-0. Epub 2017 Jul 25.
7
Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort Study.总体生活方式改变与蛋白尿发生率之间的关联:一项基于人群的队列研究。
Intern Med. 2017;56(12):1475-1484. doi: 10.2169/internalmedicine.56.8006. Epub 2017 Jun 15.
8
Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.2008 - 2012年日本特定健康检查与指导项目筛查对象的死亡风险
Clin Exp Nephrol. 2017 Dec;21(6):978-985. doi: 10.1007/s10157-017-1392-y. Epub 2017 Mar 3.
9
Trends in Chronic Kidney Disease in China.中国慢性肾脏病的发展趋势
N Engl J Med. 2016 Sep 1;375(9):905-6. doi: 10.1056/NEJMc1602469.
10
Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.挪威慢性肾脏病患病率的长期趋势及心血管危险因素的影响。
Kidney Int. 2016 Sep;90(3):665-73. doi: 10.1016/j.kint.2016.04.012. Epub 2016 Jun 22.